BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ogega CO, Skinner NE, Blair PW, Park HS, Littlefield K, Ganesan A, Dhakal S, Ladiwala P, Antar AA, Ray SC, Betenbaugh MJ, Pekosz A, Klein SL, Manabe YC, Cox AL, Bailey JR. Durable SARS-CoV-2 B cell immunity after mild or severe disease. J Clin Invest 2021;131:145516. [PMID: 33571162 DOI: 10.1172/JCI145516] [Cited by in Crossref: 46] [Cited by in F6Publishing: 50] [Article Influence: 46.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhu Q, Xu Y, Wang T, Xie F. Innate and adaptive immune response in SARS-CoV-2 infection-Current perspectives. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1053437] [Reference Citation Analysis]
2 Song R, Liu L, Pan Q, Liu J, Tan J, Deng J, Deng Q, Lin Z, Chen M, Peng M, Ren H, Ming J. Short-term safety and immunogenicity of inactivated and peptide-based SARS-CoV-2 vaccines in patients with endocrine-related cancer. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1028246] [Reference Citation Analysis]
3 Zurbuchen Y, Michler J, Taeschler P, Adamo S, Cervia C, Raeber ME, Acar IE, Nilsson J, Soyka MB, Moor AE, Boyman O. Fate and plasticity of SARS-CoV-2-specific B cells during memory and recall response in humans.. [DOI: 10.1101/2022.10.07.511336] [Reference Citation Analysis]
4 Li H, Wang Y, Ao L, Ke M, Chen Z, Chen M, Peng M, Ling N, Hu P, Cai D, Zhang D, Ren H. Association between immunosuppressants and poor antibody responses to SARS-CoV-2 vaccines in patients with autoimmune liver diseases. Front Immunol 2022;13:988004. [DOI: 10.3389/fimmu.2022.988004] [Reference Citation Analysis]
5 Dotiwala F, Upadhyay AK. A comprehensive review of BBV152 vaccine development, effectiveness, safety, challenges, and prospects. Front Immunol 2022;13:940715. [DOI: 10.3389/fimmu.2022.940715] [Reference Citation Analysis]
6 Fang S, Ju D, Lin Y, Chen W. The role of interleukin-22 in lung health and its therapeutic potential for COVID-19. Front Immunol 2022;13:951107. [DOI: 10.3389/fimmu.2022.951107] [Reference Citation Analysis]
7 Torresi J, Edeling MA, Nolan T, Godfrey DI. A Complementary Union of SARS-CoV2 Natural and Vaccine Induced Immune Responses. Front Immunol 2022;13:914167. [DOI: 10.3389/fimmu.2022.914167] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Nguyen DC, Lamothe PA, Woodruff MC, Saini AS, Faliti CE, Sanz I, Lee FE. COVID-19 and plasma cells: Is there long-lived protection? Immunol Rev 2022. [PMID: 35801537 DOI: 10.1111/imr.13115] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
9 Karger AB, Brien JD, Christen JM, Dhakal S, Kemp TJ, Klein SL, Pinto LA, Premkumar L, Roback JD, Binder RA, Boehme KW, Boppana S, Cordon-Cardo C, Crawford JM, Daiss JL, Dupuis AP 2nd, Espino AM, Firpo-Betancourt A, Forconi C, Forrest JC, Girardin RC, Granger DA, Granger SW, Haddad NS, Heaney CD, Hunt DT, Kennedy JL, King CL, Krammer F, Kruczynski K, LaBaer J, Lee FE, Lee WT, Liu SL, Lozanski G, Lucas T, Mendu DR, Moormann AM, Murugan V, Okoye NC, Pantoja P, Payne AF, Park J, Pinninti S, Pinto AK, Pisanic N, Qiu J, Sariol CA, Simon V, Song L, Steffen TL, Stone ET, Styer LM, Suthar MS, Thomas SN, Thyagarajan B, Wajnberg A, Yates JL, Sobhani K. The Serological Sciences Network (SeroNet) for COVID-19: Depth and Breadth of Serology Assays and Plans for Assay Harmonization. mSphere 2022;:e0019322. [PMID: 35703544 DOI: 10.1128/msphere.00193-22] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Zheng J, Miao J, Guo R, Guo J, Fan Z, Kong X, Gao R, Yang L. Mechanism of COVID-19 Causing ARDS: Exploring the Possibility of Preventing and Treating SARS-CoV-2. Front Cell Infect Microbiol 2022;12:931061. [DOI: 10.3389/fcimb.2022.931061] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Chen Z, Zhang Y, Song R, Wang L, Hu X, Li H, Cai D, Hu P, Shi X, Ren H. Waning humoral immune responses to inactivated SARS-CoV-2 vaccines in patients with severe liver disease. Signal Transduct Target Ther 2022;7:174. [PMID: 35654782 DOI: 10.1038/s41392-022-01032-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Roy S, Mukhopadhyay S, Mukherjee S, Samajdar S, Tripathi S. In search of protective antibody for coronavirus disease 2019: A retrospective study. Pol Ann Med 2022. [DOI: 10.29089/paom/146894] [Reference Citation Analysis]
13 Bartlett ML, Suwanmanee S, Peart Akindele N, Ghimire S, Chan AK, Guo C, Gould SJ, Cox AL, Griffin DE. Continued Virus-Specific Antibody-Secreting Cell Production, Avidity Maturation and B Cell Evolution in Patients Hospitalized with COVID-19. Viral Immunology. [DOI: 10.1089/vim.2021.0191] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Karger AB, Brien JD, Christen JM, Dhakal S, Kemp TJ, Klein SL, Pinto LA, Premkumar L, Roback JD, Binder RA, Boehme KW, Boppana S, Cordon-Cardo C, Crawford JM, Daiss JL, Dupuis AP, Espino AM, Firpo-Betancourt A, Forconi C, Forrest JC, Girardin RC, Granger DA, Granger SW, Haddad NS, Heaney CD, Hunt DT, Kennedy JL, King CL, Krammer F, Kruczynski K, LaBaer J, Lee FE, Lee WT, Liu SL, Lozanski G, Lucas T, Mendu DR, Moormann AM, Murugan V, Okoye NC, Pantoja P, Payne AF, Park J, Pinninti S, Pinto AK, Pisanic N, Qiu J, Sariol CA, Simon V, Song L, Steffen TL, Stone ET, Styer LM, Suthar MS, Thomas SN, Thyagarajan B, Wajnberg A, Yates JL, Sobhani K. The Serological Sciences Network (SeroNet) for COVID-19: Depth and Breadth of Serology Assays and Plans for Assay Harmonization. medRxiv 2022:2022. [PMID: 35262095 DOI: 10.1101/2022.02.27.22271399] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Stupica D, Collinet-Adler S, Kejžar N, Jagodic Z, Poljak M, Nahtigal Klevišar M. The Impact of SARS-CoV-2 Primary Vaccination in a Cohort of Patients Hospitalized for Acute COVID-19 during Delta Variant Predominance. J Clin Med 2022;11:1191. [PMID: 35268282 DOI: 10.3390/jcm11051191] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
16 Chivese T, Matizanadzo JT, Musa OAH, Hindy G, Furuya-kanamori L, Islam N, Al-shebly R, Shalaby R, Habibullah M, Al-marwani TA, Hourani RF, Nawaz AD, Haider MZ, Emara MM, Cyprian F, Doi SAR. The prevalence of adaptive immunity to COVID-19 and reinfection after recovery – a comprehensive systematic review and meta-analysis. Pathogens and Global Health. [DOI: 10.1080/20477724.2022.2029301] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Embong AK, Nguyen-contant P, Wang J, Kanagaiah P, Chaves FA, Fitzgerald TF, Zhou Q, Kosoy G, Branche AR, Miller BL, Zand MS, Sangster MY, Topham DJ. Formation and Expansion of Memory B Cells against Coronavirus in Acutely Infected COVID-19 Individuals. Pathogens 2022;11:186. [DOI: 10.3390/pathogens11020186] [Reference Citation Analysis]
18 Winklmeier S, Eisenhut K, Taskin D, Rübsamen H, Gerhards R, Schneider C, Wratil PR, Stern M, Eichhorn P, Keppler OT, Klein M, Mader S, Kümpfel T, Meinl E. Persistence of functional memory B cells recognizing SARS-CoV-2 variants despite loss of specific IgG. iScience 2022;25:103659. [PMID: 34957380 DOI: 10.1016/j.isci.2021.103659] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
19 Nguyen AT, Szeto C, Chatzileontiadou DS, Tong ZWM, Dewar-oldis MJ, Cooper L, Murdolo LD, Chew KY, Lineburg KE, Riboldi-tunicliffe A, Williamson R, Gardiner BJ, Jayasinghe D, Lobos CA, Ahn YM, Grant EJ, Smith C, Mcmahon J, Good-jacobson KL, Barnard PJ, Short KR, Gras S. COVID-19 vaccine booster induces a strong CD8+ T cell response against Omicron variant epitopes in HLA-A*02:01+ individuals.. [DOI: 10.1101/2022.01.12.473243] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
20 Khoo NKH, Lim JME, Gill US, de Alwis R, Tan N, Toh JZN, Abbott JE, Usai C, Ooi EE, Low JGH, Le Bert N, Kennedy PT, Bertoletti A. Differential immunogenicity of homologous versus heterologous boost in Ad26.COV2.S vaccine recipients. Med 2022. [DOI: 10.1016/j.medj.2021.12.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
21 Reyes RA, Clarke K, Gonzales SJ, Cantwell AM, Garza R, Catano G, Tragus RE, Patterson TF, Bol S, Bunnik EM. SARS-CoV-2 spike-specific memory B cells express higher levels of T-bet and FcRL5 after non-severe COVID-19 as compared to severe disease. PLoS One 2021;16:e0261656. [PMID: 34936684 DOI: 10.1371/journal.pone.0261656] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
22 Laidlaw BJ, Ellebedy AH. The germinal centre B cell response to SARS-CoV-2. Nat Rev Immunol 2021. [PMID: 34873279 DOI: 10.1038/s41577-021-00657-1] [Cited by in Crossref: 50] [Cited by in F6Publishing: 57] [Article Influence: 50.0] [Reference Citation Analysis]
23 Kantarjian HM, Zugmaier G, Brüggemann M, Wood BL, Horst HA, Zeng Y, Martinelli G. Impact of Blinatumomab Treatment on Bone Marrow Function in Patients with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia. Cancers (Basel) 2021;13:5607. [PMID: 34830762 DOI: 10.3390/cancers13225607] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Fanning SL, Korngold R, Yang Z, Goldgirsh K, Park S, Zenreich J, Baker M, McKiernan P, Tan M, Zhang B, Donato ML, Perlin DS. Elevated cytokines and chemokines in peripheral blood of patients with SARS-CoV-2 pneumonia treated with high-titer convalescent plasma. PLoS Pathog 2021;17:e1010025. [PMID: 34714894 DOI: 10.1371/journal.ppat.1010025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Sfikakis PP, Verrou KM, Ampatziadis-Michailidis G, Tsitsilonis O, Paraskevis D, Kastritis E, Lianidou E, Moutsatsou P, Terpos E, Trougakos I, Chini V, Manoloukos M, Moulos P, Pavlopoulos GA, Kollias G, Hatzis P, Dimopoulos MA. Blood Transcriptomes of Anti-SARS-CoV-2 Antibody-Positive Healthy Individuals Who Experienced Asymptomatic Versus Clinical Infection. Front Immunol 2021;12:746203. [PMID: 34675930 DOI: 10.3389/fimmu.2021.746203] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
26 Longueira Y, Polo ML, Turk G, Laufer N; InViV working group., Biobanco de Enfermedades Infecciosas Colección COVID19 working group. Dynamics of SARS-CoV-2-specific antibodies among COVID19 biobank donors in Argentina. Heliyon 2021;7:e08140. [PMID: 34642643 DOI: 10.1016/j.heliyon.2021.e08140] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
27 Kim Huat NK, Er Lim JM, Gill US, de Alwis R, Tan N, Nan Toh JZ, Abbott JE, Usai C, Ooi EE, Hong Low JG, Le Bert N, Kennedy PTF, Bertoletti A. Differential immunogenicity of homologous versus heterologous boost in Ad26.COV2.S vaccine recipients.. [DOI: 10.1101/2021.10.14.21264981] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
28 Kurt T, Sevinc I, Uysal F, Demiray E, Yilmaz H, Arslan YE. COVID-19 Tedavisinde Mezenkimal Kök Hücrelerin Potansiyel Kullanımı Üzerine Kapsamlı Bir İnceleme. Türkiye Sağlık Enstitüleri Başkanlığı Dergisi 2021. [DOI: 10.54537/tusebdergisi.983736] [Reference Citation Analysis]
29 Vigón L, García-Pérez J, Rodríguez-Mora S, Torres M, Mateos E, Castillo de la Osa M, Cervero M, Malo De Molina R, Navarro C, Murciano-Antón MA, García-Gutiérrez V, Planelles V, Alcamí J, Pérez-Olmeda M, Coiras M, López-Huertas MR. Impaired Antibody-Dependent Cellular Cytotoxicity in a Spanish Cohort of Patients With COVID-19 Admitted to the ICU. Front Immunol 2021;12:742631. [PMID: 34616404 DOI: 10.3389/fimmu.2021.742631] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
30 Wirz OF, Röltgen K, Stevens BA, Pandey S, Sahoo MK, Tolentino L, Verghese M, Nguyen K, Hunter M, Snow TT, Singh AR, Blish CA, Cochran JR, Zehnder JL, Nadeau KC, Pinsky BA, Pham TD, Boyd SD. Use of Outpatient-Derived COVID-19 Convalescent Plasma in COVID-19 Patients Before Seroconversion. Front Immunol 2021;12:739037. [PMID: 34594341 DOI: 10.3389/fimmu.2021.739037] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
31 Ligotti ME, Pojero F, Accardi G, Aiello A, Caruso C, Duro G, Candore G. Immunopathology and Immunosenescence, the Immunological Key Words of Severe COVID-19. Is There a Role for Stem Cell Transplantation? Front Cell Dev Biol 2021;9:725606. [PMID: 34595175 DOI: 10.3389/fcell.2021.725606] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
32 Reyes RA, Clarke K, Gonzales SJ, Cantwell AM, Garza R, Catano G, Tragus RE, Patterson TF, Bol S, Bunnik EM. SARS-CoV-2 spike-specific memory B cells express markers of durable immunity after non-severe COVID-19 but not after severe disease. bioRxiv 2021:2021. [PMID: 34611662 DOI: 10.1101/2021.09.24.461732] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
33 Kealy L, Good-jacobson KL. Advances in understanding the formation and fate of B-cell memory in response to immunization or infection. Oxford Open Immunology 2021;2:iqab018. [DOI: 10.1093/oxfimm/iqab018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
34 Shi L, Wang L, Xu R, Zhang C, Xie Y, Liu K, Li T, Hu W, Zhen C, Wang FS. Mesenchymal stem cell therapy for severe COVID-19. Signal Transduct Target Ther 2021;6:339. [PMID: 34497264 DOI: 10.1038/s41392-021-00754-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 17.0] [Reference Citation Analysis]
35 Chivese T, Matizanadzo JT, Musa OAH, Hindy G, Furuya-kanamori L, Islam N, Al-shebly R, Shalaby R, Habibullah M, Al-marwani T, Hourani RF, Nawaz AD, Haider MZ, Emara MM, Cyprian F, Doi SAR. The prevalence of adaptive immunity to COVID-19 and reinfection after recovery – a comprehensive systematic review and meta-analysis.. [DOI: 10.1101/2021.09.03.21263103] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
36 Untersmayr E, Förster-Waldl E, Bonelli M, Boztug K, Brunner PM, Eiwegger T, Eller K, Göschl L, Grabmeier-Pfistershammer K, Hötzenecker W, Jordakieva G, Moschen AR, Pfaller B, Pickl W, Reinisch W, Wiedermann U, Klimek L, Bergmann KC, Brehler R, Novak N, Merk HF, Rabe U, Schlenter WW, Ring J, Wehrmann W, Mülleneisen NK, Wrede H, Fuchs T, Jensen-Jarolim E. Immunologisch relevante Aspekte der neuen COVID-19-Impfstoffe : Ein Positionspapier der Österreichischen Gesellschaft für Allergologie und Immunologie (ÖGAI) und des Ärzteverbands Deutscher Allergologen (AeDA). Allergo J 2021;30:34-47. [PMID: 34393384 DOI: 10.1007/s15007-021-4848-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Dhakal S, Ruiz-Bedoya CA, Zhou R, Creisher PS, Villano JS, Littlefield K, Ruelas Castillo J, Marinho P, Jedlicka AE, Ordonez AA, Bahr M, Majewska N, Betenbaugh MJ, Flavahan K, Mueller ARL, Looney MM, Quijada D, Mota F, Beck SE, Brockhurst J, Braxton AM, Castell N, Stover M, D'Alessio FR, Metcalf Pate KA, Karakousis PC, Mankowski JL, Pekosz A, Jain SK, Klein SL; Johns Hopkins COVID-19 Hamster Study Group. Sex Differences in Lung Imaging and SARS-CoV-2 Antibody Responses in a COVID-19 Golden Syrian Hamster Model. mBio 2021;12:e0097421. [PMID: 34253053 DOI: 10.1128/mBio.00974-21] [Cited by in Crossref: 28] [Cited by in F6Publishing: 35] [Article Influence: 28.0] [Reference Citation Analysis]
38 Untersmayr E, Förster-Waldl E, Bonelli M, Boztug K, Brunner PM, Eiwegger T, Eller K, Göschl L, Grabmeier-Pfistershammer K, Hötzenecker W, Jordakieva G, Moschen AR, Pfaller B, Pickl W, Reinisch W, Wiedermann U, Klimek L, Bergmann KC, Brehler R, Pfützner W, Novak N, Merk H, Rabe U, Schlenter W, Ring J, Wehrmann W, Mülleneisen N, Wrede H, Fuchs T, Jensen-Jarolim E. Immunologically relevant aspects of the new COVID-19 vaccines-an ÖGAI (Austrian Society for Allergology and Immunology) and AeDA (German Society for Applied Allergology) position paper. Allergo J Int 2021;:1-14. [PMID: 34178577 DOI: 10.1007/s40629-021-00178-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
39 Jeffery-smith A, Burton AR, Lens S, Rees-spear C, Patel M, Gopal R, Muir L, Aiano F, Doores KJ, Chow JY, Ladhani SN, Zambon M, Mccoy LE, Maini MK. SARS-CoV-2-specific memory B cells can persist in the elderly despite loss of neutralising antibodies.. [DOI: 10.1101/2021.05.30.446322] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
40 Winklmeier S, Eisenhut K, Taskin D, Rübsamen H, Schneider C, Eichhorn P, Keppler OT, Klein M, Mader S, Kümpfel T, Meinl E. Persistence of functional memory B cells recognizing SARS-CoV-2 variants despite loss of specific IgG.. [DOI: 10.1101/2021.05.15.21257210] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
41 Meyers LM, Gutiérrez AH, Boyle CM, Terry F, McGonnigal BG, Salazar A, Princiotta MF, Martin WD, De Groot AS, Moise L. Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validation. NPJ Vaccines 2021;6:71. [PMID: 33986292 DOI: 10.1038/s41541-021-00331-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 14.0] [Reference Citation Analysis]
42 Ahluwalia P, Vaibhav K, Ahluwalia M, Mondal AK, Sahajpal N, Rojiani AM, Kolhe R. Infection and Immune Memory: Variables in Robust Protection by Vaccines Against SARS-CoV-2. Front Immunol 2021;12:660019. [PMID: 34046033 DOI: 10.3389/fimmu.2021.660019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
43 Dhakal S, Ruiz-bedoya CA, Zhou R, Creisher PS, Villano JS, Littlefield K, Castillo JR, Marinho P, Jedlicka A, Ordonez AA, Majewski N, Betenbaugh MJ, Flavahan K, Mueller AL, Looney MM, Quijada D, Mota F, Beck SE, Brockhurst J, Braxton A, Castell N, D’alessio FR, Pate KAM, Karakousis PC, Mankowski JL, Pekosz A, Jain SK, Klein SL, for the Johns Hopkins COVID-19 Hamster Study Group. Sex differences in lung imaging and SARS-CoV-2 antibody responses in a COVID-19 golden Syrian hamster model.. [DOI: 10.1101/2021.04.02.438292] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
44 Shayak B, Sharma MM, Gaur M, Mishra AK. Impact of reproduction number on the multiwave spreading dynamics of COVID-19 with temporary immunity: A mathematical model. Int J Infect Dis 2021;104:649-54. [PMID: 33444746 DOI: 10.1016/j.ijid.2021.01.018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]